Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-08

Clinical Trial Update: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial of fenofibrate in combination with ursodeoxycholic acid for primary biliary cirrhosis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: COMPLETED